230 studies found for:    "Adrenal Gland Diseases" [DISEASE]
Show Display Options
RSS Create an RSS feed from your search for:
"Adrenal Gland Diseases" [DISEASE]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening
Conditions: Adrenal Gland Diseases;   Adrenal Gland Neoplasms
Intervention: Drug: I-131 Iodocholesterol
2 Completed Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI
Condition: Adrenal Gland Disease
Intervention: Procedure: MRI
3 Recruiting Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
Condition: Adrenal Disease
Interventions: Procedure: PRA;   Procedure: LA
4 Completed Study of Cushing's Syndrome Not Related to ACTH Production
Conditions: Cushing's Syndrome;   Healthy
Intervention:
5 Recruiting Safety and Efficacy of LCI699 in Cushing's Disease Patients.
Condition: Cushing's Disease
Intervention: Drug: LCI699
6 Not yet recruiting Microvascular Function in Primary Aldosteronism
Conditions: Primary Aldosteronism;   Essential Hypertension
Interventions: Procedure: Adrenal extirpation;   Drug: Antihypertensive medication
7 Recruiting Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
8 Unknown  Evaluation of Side Effects of Mitotane
Condition: Adrenocortical Carcinoma
Intervention:
9 Completed A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection
Condition: Adrenal Cortical Carcinoma
Intervention: Drug: doxorubicin, vincristine, and etoposide with mitotane
10 Completed Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease
Condition: Cushing Disease
Intervention: Drug: Pasireotide
11 Unknown  Preoperative Bexarotene Treatment for Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Bexarotene
12 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
13 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003
14 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Intervention: Procedure: Adrenalectomy
15 Recruiting Treatment of Cushing's Disease With R-roscovitine
Condition: Cushings Disease
Intervention: Drug: R-roscovitine
16 Completed An Investigational Study of Hydrocortisone
Condition: Adrenal Insufficiency
Interventions: Drug: Infacort;   Drug: Hydrocortisone Tablet;   Drug: i.v. Hydrocortisone Injection;   Other: Dexamethasone
17 Completed Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency
Condition: Primary Adrenal Insufficiency
Interventions: Drug: Hydrocortisone intramuscular first;   Drug: Hydrocortisone subcutaneously first
18 Unknown  The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
Conditions: Hyperaldosteronism;   Hypertension
Intervention: Drug: bromocriptine
19 Recruiting HSCT for High Risk Inherited Inborn Errors
Conditions: Adrenoleukodystrophy;   Metachromatic Leukodystrophy;   Globoid Cell Leukodystrophy;   Tay Sachs Disease;   Sandhoffs Disease;   Wolman Disease;   I-Cell Disease;   Sanfilippo Syndrome;   GM1 Gangliosidosis
Interventions: Drug: Clofarabine;   Procedure: Total body Irradiation;   Drug: Melphalan;   Biological: Hematopoietic Stem Cell Transplantation;   Drug: Alemtuzumab;   Drug: mycophenylate mofetil;   Device: Cyclosporine A;   Drug: Hydroxyurea
20 Completed
Has Results
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years